|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
|
JP2002534468A
(ja)
|
1999-01-13 |
2002-10-15 |
バイエル コーポレイション |
ｐ３８キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素
|
|
US20030216396A1
(en)
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
|
PT1478358E
(pt)
|
2002-02-11 |
2013-09-11 |
Bayer Healthcare Llc |
Tosilato de sorafenib para o tratamento de doenças caracterizadas por angiogénese anormal
|
|
DK1499311T3
(da)
*
|
2002-03-29 |
2010-03-08 |
Novartis Vaccines & Diagnostic |
Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
WO2004110990A2
(en)
|
2003-05-15 |
2004-12-23 |
Arqule, Inc. |
Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
|
|
PL1626714T3
(pl)
|
2003-05-20 |
2007-12-31 |
Bayer Healthcare Llc |
Diarylowe pochodne mocznika do schorzeń, w których pośredniczy PDGFR
|
|
CN102816113B
(zh)
|
2003-07-23 |
2015-05-13 |
拜耳医药保健有限责任公司 |
用于治疗和预防疾病和疾病症状的氟代ω-羧芳基二苯基脲
|
|
US7423150B2
(en)
*
|
2003-10-16 |
2008-09-09 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of Raf kinase
|
|
US7829560B2
(en)
*
|
2004-07-08 |
2010-11-09 |
Arqule, Inc. |
1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
|
|
WO2006044869A1
(en)
*
|
2004-10-19 |
2006-04-27 |
Arqule, Inc. |
Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
|
|
WO2006078907A1
(en)
*
|
2005-01-20 |
2006-07-27 |
Amgen Inc. |
2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments
|
|
TWI370820B
(en)
*
|
2005-04-27 |
2012-08-21 |
Takeda Pharmaceutical |
Fused heterocyclic compounds
|
|
TW200804345A
(en)
*
|
2005-08-30 |
2008-01-16 |
Novartis Ag |
Substituted benzimidazoles and methods of preparation
|
|
EP1943226A2
(en)
*
|
2005-10-13 |
2008-07-16 |
Smithkline Beecham Corporation |
Phenol ethers as modulators of the opioid receptors
|
|
EP1987028A2
(en)
|
2006-02-10 |
2008-11-05 |
Transtech Pharma, Inc. |
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
|
|
ES2654847T3
(es)
|
2006-04-19 |
2018-02-15 |
Novartis Ag |
Compuestos de benzoxazol y benzotiazol sustituidos en 6-O y métodos para inhibir la señalización CSF-1R
|
|
CN101516335B
(zh)
|
2006-07-21 |
2014-01-08 |
诺瓦提斯公司 |
苯并咪唑基吡啶基醚的制剂
|
|
PE20130814A1
(es)
*
|
2006-08-30 |
2013-08-08 |
Novartis Ag |
Sales de benzimidazolil piridil eteres y formulaciones que las contienen
|
|
KR20090126286A
(ko)
*
|
2007-04-05 |
2009-12-08 |
다이이찌 산쿄 가부시키가이샤 |
축합 2 고리형 헤테로아릴 유도체
|
|
TW200904816A
(en)
|
2007-06-05 |
2009-02-01 |
Takeda Pharmaceutical |
Fused heterocycle derivatives and use thereof
|
|
EP2181987B9
(en)
|
2007-08-23 |
2014-09-03 |
Takeda Pharmaceutical Company Limited |
2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer
|
|
EP2184285B1
(en)
*
|
2007-08-29 |
2015-11-04 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
|
UA101166C2
(ru)
|
2007-09-21 |
2013-03-11 |
Аррей Биофарма Инк. |
Производные пиридин-2-иламино-1,2,4-тиадиазола как активаторы глюкокиназы для лечения сахарного диабета
|
|
US20100261679A1
(en)
*
|
2007-10-18 |
2010-10-14 |
James Sutton |
CSF-1R, Inhibitors, Compositions, and Methods of Use
|
|
US8697874B2
(en)
*
|
2008-12-01 |
2014-04-15 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
|
JO3101B1
(ar)
|
2008-12-02 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مشتقات بنزوثيازول كعوامل مضادة للسرطان
|
|
EP2361254A1
(en)
*
|
2008-12-05 |
2011-08-31 |
ArQule, Inc. |
Raf inhibitors and their uses
|
|
ES2617191T3
(es)
|
2009-03-05 |
2017-06-15 |
Daiichi Sankyo Company, Limited |
Derivado de piridina como inhibidor de PPARY
|
|
AU2011265254B2
(en)
|
2010-06-11 |
2016-05-19 |
Smith & Nephew, Inc. |
Patient-matched instruments
|
|
US9120752B2
(en)
|
2010-07-16 |
2015-09-01 |
Purdue Pharma, L.P. |
Pyridine compounds as sodium channel blockers
|
|
BR112013006272A2
(pt)
|
2010-09-17 |
2019-09-24 |
Purdue Pharma Lp |
compostos de piridina e seus usos
|
|
CN102276482A
(zh)
*
|
2011-04-11 |
2011-12-14 |
常州大学 |
2-甲氧基-5-溴苯胺的制备方法
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
WO2013136170A1
(en)
|
2012-03-16 |
2013-09-19 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
CN103435554A
(zh)
*
|
2013-09-06 |
2013-12-11 |
中国药科大学 |
2-苯氨基苯并咪唑类化合物及其用途
|
|
EP3046557A1
(en)
|
2013-09-20 |
2016-07-27 |
Stichting Het Nederlands Kanker Instituut |
Rock in combination with mapk-pathway
|
|
WO2015041534A1
(en)
|
2013-09-20 |
2015-03-26 |
Stichting Het Nederlands Kanker Instituut |
P90rsk in combination with raf/erk/mek
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
US20170027940A1
(en)
|
2014-04-10 |
2017-02-02 |
Stichting Het Nederlands Kanker Instituut |
Method for treating cancer
|
|
WO2015178770A1
(en)
|
2014-05-19 |
2015-11-26 |
Stichting Het Nederlands Kanker Instituut |
Compositions for cancer treatment
|
|
UY36294A
(es)
|
2014-09-12 |
2016-04-29 |
Novartis Ag |
Compuestos y composiciones como inhibidores de quinasa
|
|
AU2015362790A1
(en)
|
2014-12-16 |
2017-07-20 |
Axovant Sciences Gmbh |
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
|
|
CN105949178B
(zh)
*
|
2015-03-09 |
2020-05-26 |
西格莱(苏州)生物医药有限公司 |
一种苯并咪唑类化合物、其制备方法、中间体及应用
|
|
MX2017016231A
(es)
|
2015-06-10 |
2018-11-29 |
Axovant Sciences Gmbh |
Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina.
|
|
US10428062B2
(en)
|
2015-08-12 |
2019-10-01 |
Axovant Sciences Gmbh |
Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors
|
|
KR101770310B1
(ko)
|
2015-08-24 |
2017-08-24 |
이화여자대학교 산학협력단 |
2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
|
|
WO2017095950A2
(en)
*
|
2015-11-30 |
2017-06-08 |
Children's Medical Center Corporation |
Compounds for treating proliferative diseases
|
|
EP3515446B1
(en)
|
2016-09-19 |
2023-12-20 |
Novartis AG |
Therapeutic combinations comprising a raf inhibitor and a erk inhibitor
|
|
CN106674264A
(zh)
*
|
2016-12-20 |
2017-05-17 |
苏州汉德创宏生化科技有限公司 |
(2,2,2‑三氟乙氧基)苯硼酸类化合物的合成方法
|
|
US11471538B2
(en)
|
2017-02-10 |
2022-10-18 |
INSERM (Institut National de la Santéet de la Recherche Medicale) |
Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway
|
|
JP7094942B2
(ja)
|
2017-03-15 |
2022-07-04 |
住友ファーマ株式会社 |
ベンズイミダゾール誘導体の製造方法
|
|
DK3618875T3
(da)
|
2017-05-02 |
2023-07-10 |
Novartis Ag |
Kombinationsterapi omfattende en raf-inhibitor og trametinib
|
|
US11299488B2
(en)
*
|
2017-07-12 |
2022-04-12 |
Bristol-Myers Squibb Company |
Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure
|
|
EP3700904B1
(en)
|
2017-10-24 |
2023-07-19 |
Bayer AG |
4h-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
EP3732285A1
(en)
|
2017-12-28 |
2020-11-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
|
CN111788183B
(zh)
*
|
2018-02-07 |
2024-02-23 |
韩国化学硏究院 |
用于抑制tnik的杂环融合苯基化合物及其医疗用途
|
|
WO2020055760A1
(en)
|
2018-09-10 |
2020-03-19 |
Mirati Therapeutics, Inc. |
Combination therapies
|
|
WO2020097398A1
(en)
|
2018-11-07 |
2020-05-14 |
Dana-Farber Cancer Institute, Inc. |
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
US12403135B2
(en)
|
2019-04-24 |
2025-09-02 |
Bayer Aktiengesellschaft |
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
TWI849114B
(zh)
|
2019-04-24 |
2024-07-21 |
德商拜耳廠股份有限公司 |
4H-吡咯并[3,2-c]吡啶-4-酮化合物
|
|
WO2020216773A1
(en)
|
2019-04-24 |
2020-10-29 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one compounds
|
|
KR102881316B1
(ko)
|
2019-05-13 |
2025-11-05 |
노파르티스 아게 |
암 치료를 위한 raf 억제제로서의 n-(3-(2-(2-하이드록시에톡시)-6-모르폴리노피리딘-4-일)-4-메틸페닐)-2 (트리플루오로메틸)이소니코틴아미드의 새로운 결정질 형태
|
|
WO2021198020A1
(en)
|
2020-03-31 |
2021-10-07 |
Bayer Aktiengesellschaft |
3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer
|
|
WO2021226261A1
(en)
*
|
2020-05-06 |
2021-11-11 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
EP4263531A2
(en)
*
|
2020-12-16 |
2023-10-25 |
IFM Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
|
EP4267574B1
(en)
|
2020-12-23 |
2025-04-23 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
WO2023009708A1
(en)
*
|
2021-07-29 |
2023-02-02 |
Ajax Therapeutics, Inc. |
Heteroaryloxy triazolo- and imidazo-azines as jak2 inhibitors
|
|
US12162881B2
(en)
|
2021-11-09 |
2024-12-10 |
Ajax Therapeutics, Inc. |
Forms and compositions of inhibitors of JAK2
|
|
CA3234638A1
(en)
|
2021-11-09 |
2023-05-19 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|